10-K · June 29, 2026
Modular Medical, Inc. is a commercial-stage medical device company focused on developing innovative insulin delivery systems. The 10-K reflects a challenging financial situation, with significant operating losses of…
Earnings analysis · 10-Q
MODD earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
The extracted 10-Q does not include the statements of operations, balance sheet detail, cash-flow amounts, or segment disclosures, so revenue, margins, EPS, free cash flow, and quarter-over-quarter trends cannot be…
Read full summary
The extracted 10-Q does not include the statements of operations, balance sheet detail, cash-flow amounts, or segment disclosures, so revenue, margins, EPS, free cash flow, and quarter-over-quarter trends cannot be quantified from the available text. Liquidity remains the dominant issue: the company had $3.9 million of cash and an accumulated deficit of approximately $119.4 million at June 30, 2026, and stated that additional capital is needed even after $5.1 million of post-quarter-end ATM proceeds. Management’s explicit going-concern warning and expected ongoing losses support a bearish assessment.
What stood out
-
$8.8M of Recent Financing Proceeds
The company raised approximately $3.0 million in net proceeds from an April 2026 registered direct offering, approximately $0.7 million through its ATM program in June 2026, and approximately $5.1 million through the ATM program after June 30, 2026.
-
Disclosure Controls Remained Effective
Management concluded that disclosure controls and procedures were effective as of June 30, 2026, and reported no change during the 3 months ended June 30, 2026 that materially affected internal control over financial reporting.
What to watch
-
Going-Concern Warning and Funding Need
The company reported cash and cash equivalents of $3.9 million and an accumulated deficit of approximately $119.4 million as of June 30, 2026. Despite approximately $5.1 million of post-quarter-end ATM proceeds, management stated that cash will not be sufficient to fund operations for the 12 months from the report date and that additional capital is required, creating substantial doubt about the ability to continue as a going concern.
-
Dependence on Additional Capital
The company expects operating losses and cash burn for the foreseeable future and stated that it intends to seek additional financing. If new debt or equity is issued, existing holders may face dilution; failure to obtain financing could require curtailing product development, cutting operating costs, or terminating operations.
-
Limited Risk-Factor Updates
The filing states that, other than the going-concern disclosure, there were no material changes to the risk factors in the March 31, 2026 Form 10-K. This limits evidence of new risk-factor developments but confirms that the going-concern risk was specifically elevated in the current filing.
Management's outlook
No quantitative revenue or EPS guidance was provided in the extracted 10-Q text; outlook was deferred to the earnings press release or call.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.